{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006119",
      "entity_text" : "OXPHOS",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:4091",
      "entity_text" : "metformin",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "First, the results of several studies are inconsistent with the hypothesis that the anti-diabetic and growth inhibitory effects of metformin are linked to the activation of AMPK : i) studies using AMPK knockout mice have demonstrated that metformin inhibits mitochondrial OXPHOS Complex I and induces changes in the energy state, which is solely responsible for the inhibition of gluconeogenesis; ii) it has been suggested that the growth inhibitory effects of metformin are due to AMPK activation, leading to the inhibition of the mTOR pathway.",
  "reading_complete" : "2020-08-03T15:57:17Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T15:52:35Z",
  "trigger" : "inhibits",
  "evidence" : [ "metformin inhibits mitochondrial OXPHOS" ],
  "pmc_id" : "3868499",
  "score" : 0
}